Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,168 | 11 | 92.1% |
| Education | $99.95 | 1 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $249.04 | 2 | $0 (2022) |
| GENZYME CORPORATION | $247.16 | 2 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $125.16 | 1 | $0 (2021) |
| ADC Therapeutics America, Inc. | $122.75 | 1 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $113.16 | 1 | $0 (2020) |
| Celgene Corporation | $112.65 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $102.56 | 1 | $0 (2022) |
| Epizyme, Inc., | $99.95 | 1 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $95.87 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.87 | 2 | Janssen Scientific Affairs, LLC ($95.87) |
| 2022 | $222.41 | 2 | Incyte Corporation ($119.85) |
| 2021 | $836.86 | 7 | GENZYME CORPORATION ($247.16) |
| 2020 | $113.16 | 1 | Pharmacyclics LLC, An AbbVie Company ($113.16) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | Janssen Scientific Affairs, LLC | TALVEY (Biological), CARVYKTI, TECVAYLI | Food and Beverage | In-kind items and services | $67.96 | General |
| Category: Oncology | ||||||
| 01/31/2024 | Janssen Scientific Affairs, LLC | TECVAYLI (Biological), CARVYKTI, DARZALEX | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Oncology | ||||||
| 04/27/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $102.56 | General |
| 03/23/2022 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $119.85 | General |
| Category: Hematology/Oncology | ||||||
| 12/15/2021 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $122.75 | General |
| 11/18/2021 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $129.19 | General |
| Category: Hematology/Oncology | ||||||
| 11/10/2021 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $112.65 | General |
| Category: Hematology | ||||||
| 11/04/2021 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | Cash or cash equivalent | $125.16 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/07/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hematology | ||||||
| 08/03/2021 | Epizyme, Inc., | TAZVERIK (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $122.16 | General |
| Category: Hematology | ||||||
| 01/30/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $113.16 | General |
| Category: Oncology | ||||||
About Dr. Patrick Moore, M.D
Dr. Patrick Moore, M.D is a Hematology & Oncology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2016. The National Provider Identifier (NPI) number assigned to this provider is 1639525371.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Moore, M.D has received a total of $1,268 in payments from pharmaceutical and medical device companies, with $95.87 received in 2024. These payments were reported across 12 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,168).
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hospitalist
- Location Stanford, CA
- Active Since 05/12/2016
- Last Updated 09/17/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1639525371
Products in Payments
- JAKAFI (Drug) $249.04
- CABLIVI (Biological) $247.16
- VYXEOS (Drug) $125.16
- Imbruvica (Drug) $113.16
- REBLOZYL (Biological) $112.65
- TAZVERIK (Drug) $99.95
- TALVEY (Biological) $67.96
- TECVAYLI (Biological) $27.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Stanford
Everett Meyer, Md Phd, MD PHD
Hematology & Oncology — Payments: $2.1M
Sandra Horning, M.d, M.D
Hematology & Oncology — Payments: $1.9M
George Fisher, Md, MD
Hematology & Oncology — Payments: $202,617
Joel Neal, M.d., Ph.d, M.D., PH.D
Hematology & Oncology — Payments: $169,917
Lipika Goyal, Md, MD
Hematology & Oncology — Payments: $157,376
David Miklos, M.d., Ph. D, M.D., PH. D
Hematology & Oncology — Payments: $131,666